Cite
HARVARD Citation
Ostendorf, B. et al. (2005). Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis. Annals of the rheumatic diseases. 64 (4), pp. 630-633. [Online].